Xyrem is a powerful central nervous system depressant manufactured and distributed by Orphan Medical (since acquired by Jazz Pharmaceuticals).

FORBES: Off-Label Pharma Prosecutions Won't Be Silenced By First Amendment Decision

Amylin Pharmaceuticals (AMLN), Xoma (XOMA) and Jazz Pharmaceuticals (JAZZ) are among companies selling stock to raise cash in recent weeks.

FORBES: For Biotech, 'Fail' is Making a Big Comeback

This morning, a panel of FDA experts is reviewing Rekinla, from Jazz Pharmaceuticals, as a treatment for fibromyalgia, a type of chronic pain.

FORBES: The FDA's New Power